检索结果 - Anjali Kumar
- Showing 1 - 9 results of 9
-
1
-
2
-
3
-
4
-
5
-
6
-
7
Humoral and cellular responses to repeated COVID-19 exposure in multiple sclerosis patients receiving B-cell depleting therapies: a single-center, one-year, prospective study 由 Roberto Alfonso-Dunn, Jerry Lin, Joyce Lei, Jiayuan Liu, Morgan Roche, Antonia De Oliveira, Amol Raisingani, Anjali Kumar, Vanessa Kirschner, Grant Feuer, Michaela Malin, Saud A. Sadiq
发表在 Frontiers in Immunology (2023-06-01)获取全文
文件 -
8
Efficacy of intrathecal mesenchymal stem cell-neural progenitor therapy in progressive MS: results from a phase II, randomized, placebo-controlled clinical trial 由 Violaine K. Harris, James Stark, Armistead Williams, Morgan Roche, Michaela Malin, Anjali Kumar, Alyssa L. Carlson, Cara Kizilbash, Jaina Wollowitz, Caroline Andy, Linda M. Gerber, Saud A. Sadiq
发表在 Stem Cell Research & Therapy (2024-05-01)获取全文
文件 -
9
Efficacy of quality improvement and patient safety workshops for students: a pilot study 由 Kevin P. Shah, Shreya Goyal, Vignesh Ramachandran, Jaden R. Kohn, Jonathan A. Go, Zachary Wiley, Anoosha Moturu, Meera K. Namireddy, Anjali Kumar, Ryan C. Jacobs, Matthew Stampfl, Jesal R. Shah, Justin Fu, Weijie V. Lin, Brandon Ho, Grace Wey, Sophie Y. Lin, Andrew C. Caruso, Lindsey Jordan Gay, Diana E. Stewart, Sara Andrabi
发表在 BMC Medical Education (2020-04-01)获取全文
文件
